An audio visual education module and detailed primer on male infertility, its origins, anatomy and physiology and treatment.

Platelet-activating factor (PAF) is present in human spermatozoa, and its content has a significant and positive relationship with motility and pregnancy rate.

A chart with normal ranges for sperm or semen analysis

To evaluate the effect of aspirin on infertile women with thin endometrium, 114 women were placed into an aspirin group and 122 women into a nonaspirin group

Amy and Todd have been trying to conceive for 2 years. Initially, when they decided to start a family, Todd was certain they would become pregnant very quickly. In his previous marriage, Todd had conceived each of his two children, now 20 and 22 years old, within 3 months. However, on Amy's 35th birthday, the couple realized they could no longer explain away their problem and decided to consult a fertility specialist.

Couples and individuals facing reproductive choices have many options available to them today. Just a few decades ago, if a patient needed donor sperm their physician made all the choices for them and had little information to share about the donor.

In any field of medical research, success is often measured in minute degrees, the impact of which may only be known to those whose careers are spent in the laboratories. Occasionally, however, there comes a discovery so astounding that it revolutionizes medical procedure. Such is the case with Intracytoplasmic Sperm Injection, or ICSI, a new infertility treatment utilizing micromanipulation technology that specifically addresses male factor infertility issues. ICSI is so remarkable, in fact, that most treatments previously used have been abandoned in its favor.

IVIG is used to treat reproductive immunological problems including multiple miscarriage and implantation failure. This template letter for pre-treatment medical necessity can be sent to insurance companies as a routine appeal for use of IVIg or Intravenous Immunoglobulin

IVig (intravenous immunoglobulin) is an expensive treatment for both implantation failure as well as multiple miscarriages resulting from reproductive immunological complications. Here is a pre-treatment sample letter for medical necessity or a post treatment appeal for use of this very expensive medication.

The complexity of the immune system can be key in treating both implantation failure and pregnancy loss.

Recently there has been recognition that implanting embryos engage in a “cross talk” allowing it to develop unhindered in the uterus rather than be rejected. The embryo, upon arrival in the uterus, relays its desire to enter into a “dialogue” with the endometrial immune system. What this might mean to implantation is discussed by Geoffrey Sher,M.D.

A 1995 study evaluating the efficacy of intravenous immunoglobulin for treatment of individuals experiencing unexplained recurrent pregnancy loss.